Tofacitinib Tablet, Film Coated
NDC 70771-1821
Product Information
Tofacitinib is a ANDA-approved product labeled by Zydus Lifesciences Limited. This medication is typically used as a janus kinase inhibitor [epc]. It is supplied as a white tablet, film coated for oral administration. This product entry covers the primary NDC 70771-1821 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
1243 Code Structure Chart
Product Details
What is NDC 70771-1821?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOFACITINIB CITRATE (UNII: O1FF4DIV0D)
- TOFACITINIB (UNII: 87LA6FU830) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- POVIDONE K30 (UNII: U725QWY32X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1357541 - tofacitinib 5 MG Oral Tablet
- RxCUI: 1357541 - tofacitinib 5 MG (as tofacitinib citrate 8.08 MG) Oral Tablet
- RxCUI: 2048566 - tofacitinib 10 MG Oral Tablet
- RxCUI: 2048566 - tofacitinib 10 MG (as tofacitinib citrate 16.16 MG) Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.